Inhibition of the LINE1-derived MET transcript induces apoptosis and oncoprotein knockdown in cancer cells
Open Access
- 1 April 2025
- journal article
- Published by Elsevier in Molecular Therapy Nucleic Acids
- Vol. 36 (2) , 102529
Abstract
No abstract availableKeywords
Funding Information
- Ministero della Salute (521 D15D18000410001)
- Leukemia and Lymphoma Society
This publication has 50 references indexed in Scilit:
- MET Tyrosine Kinase Inhibitor Crizotinib (PF-02341066) Shows Differential Antitumor Effects in Non-small Cell Lung Cancer According to MET AlterationsJournal of Thoracic Oncology, 2011
- Down-modulation of cancer targets using locked nucleic acid (LNA)-based antisense oligonucleotides without transfectionGene Therapy, 2010
- A coding-independent function of gene and pseudogene mRNAs regulates tumour biologyNature, 2010
- Demethylation of a LINE-1 antisense promoter in the cMet locus impairs Met signalling through induction of illegitimate transcriptionOncogene, 2010
- Efficient gene silencing by delivery of locked nucleic acid antisense oligonucleotides, unassisted by transfection reagentsNucleic Acids Research, 2009
- MicroRNA-1/206 Targets c-Met and Inhibits Rhabdomyosarcoma DevelopmentJournal of Biological Chemistry, 2009
- MET increased gene copy number and primary resistance to gefitinib therapy in non-small-cell lung cancer patientsAnnals of Oncology, 2008
- Many Human Genes Are Transcribed from the Antisense Promoter of L1 RetrotransposonGenomics, 2002
- Antisense Promoter of Human L1 Retrotransposon Drives Transcription of Adjacent Cellular GenesMolecular and Cellular Biology, 2001
- c-met is amplified but not mutated in a cell line with an activated met tyrosine kinase.1991